CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,034 Cr | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr |
What is the latest Total Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,034 Cr |
| Mar2024 | ₹1,701 Cr |
| Mar2023 | ₹1,514 Cr |
| Mar2022 | ₹1,502 Cr |
| Mar2021 | ₹1,313 Cr |
How is Total Liabilities of CONCORD BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,034 Cr | 19.61 | |
| Mar2024 | ₹1,701 Cr | 12.33 | |
| Mar2023 | ₹1,514 Cr | 0.81 | |
| Mar2022 | ₹1,502 Cr | 14.41 | |
| Mar2021 | ₹1,313 Cr | - | |
Compare Total Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,043.1 Cr | 13.4% | 4.4% | -27.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 13.4% |
4.4% |
-27.3% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses